Trial Profile
Efficacy and Safety of Empagliflozin Compared With Linagliptin in New-onset Diabetes Mellitus After Kidney Transplantation
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2023
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary) ; Linagliptin (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 22 Nov 2023 Status changed from recruiting to discontinued.
- 28 Aug 2018 New trial record